Stock Movers Closing Bell: Moderna and Nathan's Surges, Kraft Heinz Declines on Berkshire Sale
Jan 21, 2026
Listen in as Moderna's shares soar after promising cancer therapy results. The buzz around Nathan's Famous grows with Smithfield Foods' acquisition for $450 million. Meanwhile, Kraft Heinz takes a dip as Berkshire Hathaway lists over 325 million shares for sale. The team also discusses the impact of rising programming costs on Netflix and the fluctuations in software stocks. Tune in for all the market highlights and insights!
AI Snips
Chapters
Transcript
Episode notes
Moderna Rally From Long-Term Cancer Data
- Moderna's cancer vaccine data boosted its stock substantially, reflecting strong investor reaction to long-term clinical results.
- The company's personalized therapy showed prevention of high-risk skin cancer recurrence after five years, driving momentum.
Hot Dog Deal Sparks Studio Banter
- Nathan's Famous jumped after Smithfield Foods agreed to buy the brand for about $450 million, surprising the hosts with the price for hot dogs.
- Carol Massar noted the cultural tie and Tim Stenovec joked about wanting the Nathan's story for the Gainers segment.
Deal Ties Nathan's To Foreign Ownership
- Smithfield's acquisition of Nathan's links a New York icon to a company with significant Chinese ownership via WH Group.
- That ownership has previously drawn scrutiny from the U.S. government, adding geopolitical context to the deal.